Answer: Australia is the first country worldwide to approve MDMA for PTSD and psilocybin for hard-to-treat depression. The Therapeutic Goods Administration put the two drugs on the approved medicines list starting July 1, 2023, but for a price — the treatment costs about $10,000 (Australian. It’s roughly $6,600 US dollars) per patient._x000D__x000D_

More Questions and Answers